EUVIMEDEUVIMED entdecken
Open Access

Targeting of Cdc42‐Interacting Protein 4‐Calcineurin Signalosomes Improves Cardiac Structure and Function After Myocardial Infarction

Anne-Maj Samuelsson iD, Abraham L Bayer iD, Jinliang Li iD, Yang Li, DeEsmond Lewis, Moriah G Turcotte iD, Kimberly L Dodge-Kafka iD, Pilar Alcaide iD, Michael S Kapiloff iD

Journal of the American Heart Association · 2026

DOI: 10.1161/jaha.125.044692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Anne-Maj Samuelsson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Ophthalmology and Medicine Stanford Cardiovascular Institute, Stanford University Palo Alto CA USA. Hauptthemen laut MEDLINE: Myocardial Infarction, Ventricular Remodeling, Calcineurin, Myocardial Reperfusion Injury. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

CaN (calcineurin) promotes pathological cardiac remodeling but also cardioprotection in ischemia–reperfusion injury. CaN inhibitors are also immunosuppressants. This pleiotropy complicates targeting calcineurin in cardiovascular disease. CIP4/TRIP10 (Cdc42‐interacting protein 4) is a scaffold protein that binds the CaNAβ (calcineurin Aβ) N‐terminal polyproline domain and organizes a calcium and CaNAβ2 signaling compartment independent of contractile calcium. We showed that CIP4‐CaNAβ2 signalosomes promote pathological cardiac hypertrophy induced by pressure overload. It is unknown whether CIP4‐CaNAβ2 signalosomes contribute to cardioprotection and remodeling in ischemic disease.

Methods

CIP4 conditional knockout mice were studied following ischemia–reperfusion and permanent left coronary artery ligation that induce myocardial infarction. C57BL/6NJ mice were transduced with cardiotropic adeno‐associated virus expressing a CaNAβ2 small hairpin RNA to inhibit CaNAβ2 expression, a VIVIT peptide to inhibit CaN‐NFAT (nuclear factor of activated T cells) signaling, or a CaNAβ polyproline peptide to block CIP4‐CaNAβ2 binding and similarly studied by ischemia–reperfusion injury and left coronary artery ligation. CaNAβ polyproline‐dependent signaling was also studied in T cells.

Results

CIP4 conditional knockout and cardiomyocyte‐specific CaNAβ polyproline peptide expression improved cardiac function after ischemia–reperfusion injury and decreased infarct size and improved cardiac function after permanent left coronary artery ligation. In contrast, cardiomyocyte‐specific CaNAβ2 depletion and VIVIT expression worsened outcome after myocardial infarction. The polyproline peptide had no effect on T‐cell activation and cytokine expression in vitro.

Conclusions

CIP4‐CaNAβ2 signalosomes promote adverse cardiac remodeling and are not cardioprotective. Proof of concept is provided for the treatment of ischemic cardiomyopathy by a polyproline peptide gene therapy. Targeting these complexes may be beneficial in cardiovascular diseases, including ischemic cardiomyopathy and acute myocardial infarction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionVentricular RemodelingCalcineurinMyocardial Reperfusion InjuryVentricular Function, LeftAnimalsMice, Inbred C57BLMice, KnockoutDisease Models, AnimalMyocytes, CardiacSignal TransductionMaleMice

Stichwörter der Autor:innen

CIP4calcineurinheart failuremyocardial infarctionsignal transduction

Substanzen

Calcineurin

Autor:innen und Institutionen

  • Departments of Ophthalmology and Medicine Stanford Cardiovascular Institute, Stanford University Palo Alto CA USA.
  • Department of Immunology Tufts University School of Medicine Boston MA USA.
  • Calhoun Center for Cardiology, University of Connecticut Health Center Farmington CT USA.

ORCID-Profile: Anne-Maj Samuelsson, Abraham L Bayer, Jinliang Li, Moriah G Turcotte, Kimberly L Dodge-Kafka, Pilar Alcaide, Michael S Kapiloff

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Samuelsson, A. M., Bayer, A. L., Li, J., Li, Y., Lewis, D., Turcotte, M. G., Dodge-Kafka, K. L., Alcaide, P., & Kapiloff, M. S. (2026). Targeting of Cdc42‐Interacting Protein 4‐Calcineurin Signalosomes Improves Cardiac Structure and Function After Myocardial Infarction. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.044692

Vancouver

Samuelsson AM, Bayer AL, Li J, Li Y, Lewis D, Turcotte MG, et al. Targeting of Cdc42‐Interacting Protein 4‐Calcineurin Signalosomes Improves Cardiac Structure and Function After Myocardial Infarction. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.044692

BibTeX
@article{Samuelsson2026,
  author = {Samuelsson, Anne-Maj and Bayer, Abraham L and Li, Jinliang and Li, Yang and Lewis, DeEsmond and Turcotte, Moriah G and Dodge-Kafka, Kimberly L and Alcaide, Pilar and Kapiloff, Michael S},
  title = {Targeting of Cdc42‐Interacting Protein 4‐Calcineurin Signalosomes Improves Cardiac Structure and Function After Myocardial Infarction},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.125.044692}
}
Kostenlos starten →